Renzi, G.* ; Higos, R.* ; Vlassakev, I.* ; Bello, A.A.* ; Omar-Hmeadi, M.* ; Hansen, M.* ; Merabtene, F.* ; Rouault, C.* ; Hodek, O.* ; Massier, L. ; Antonny, B.* ; Marcelin, G.* ; Rahbani, J.F.* ; Lecoutre, S.* ; Maqdasy, S.*
Creatine kinase B regulates glycolysis and de novo lipogenesis pathways to control lipid accumulation during adipogenesis.
Cell Rep. 44, 22:116489 (2025)
White adipocyte differentiation or adipogenesis requires coordination of metabolic sensing and transcriptional modifications to orchestrate lipid storage. Creatine and its kinases are implicated in adipose energy buffering, but the roles of cytosolic (CKB) and mitochondrial (CKMT2) creatine kinases in adipogenesis are unclear. We find that both CKB and CKMT2 are progressively upregulated during differentiation. Functional studies show that CKB restrains de novo lipogenesis (DNL) by limiting activation of carbohydrate-responsive element-binding protein (ChREBP), a key regulator of lipogenic genes. Mechanistically, CKB interacts with AKT and regulates its activation in response to insulin. Loss of CKB causes persistent AKT-mTORC1 signaling, increases glycolytic flux, and enhances ChREBP activation, thereby promoting glucose-derived lipid synthesis. Thus, CKB acts as a metabolic rheostat linking creatine-kinase activity to insulin signaling and nutrient-responsive transcription. We propose a CKB-AKT-ChREBP regulatory axis that contributes to metabolic remodeling and lipid homeostasis during adipocyte differentiation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Akt-mtorc ; Ckb ; Cp: Metabolism ; Chrebp ; Adipogenesis ; Creatine Kinase ; De Novo Lipogenesis ; White Adipocyte; Creatine Supplementation Prevents; Depot-specific Differences; Diet-induced Obesity; De-novo Lipogenesis; Adipose-tissue; Human Adipocyte; Insulin-resistance; Mammalian Protein; Gene-expression; Fatty Liver
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
0
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 44,
Heft: 11,
Seiten: 22,
Artikelnummer: 116489
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-506509-001
Förderungen
CIMED, European Foundation for the Study of Diabetes Rising Star award
Swedish Research Council
French National Agency for Research
European Research Council (ERC Synergy grant SPHERES)
Copyright
Erfassungsdatum
2025-11-07